# Determination of Residual Anticoagulatory Effects of Fondaparinux

> **NCT01101256** · — · UNKNOWN · sponsor: **Johann Wolfgang Goethe University Hospital** · enrollment: 110 (estimated)

## Conditions studied

- Anticoagulant Prophylaxis/Therapy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01101256
- **Lead sponsor:** Johann Wolfgang Goethe University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-04
- **Primary completion:** 2010-09
- **Final completion:** 2010-10
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2010-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01101256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01101256, "Determination of Residual Anticoagulatory Effects of Fondaparinux". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01101256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*